Funding
Funding
Funded Projects
Home → Funding→ Funded Projects
Funded Projects
The VIE-Qc program: Integrative interventions for pediatric oncology patients during treatment – Priorité Patient
Principal Investigator
Valérie Marcil
Competition
Priorité Patient 2
Status
Ongoing
Budget
$200,000
See the project
Scaling up PAROLE-Onco+: The care and service partnership for patients and their loved ones affected by cancer to improve their experience throughout the care trajectory – Priorité Patient
Principal Investigators
Marie-Pascale Pomey
Competition
Priorité Patient 2
Status
Ongoing
Budget
$200,000
See the project
Impacts of an innovative virtual speech-language pathology and patient-guided swallowing group-based intervention to prevent swallowing disorders in patients treated with chemoradiation for head and neck cancer in a speciality care setting – Priorité Patient
Principal Investigator
Marie-Ève Caty
Competition
Priorité Patient 2
Status
Ongoing
Budget
$198,000
See the project
Development and evaluation of an intervention program combining virtual reality and hypnosis to support patients with multiple myeloma – Priorité Patient
Principal Investigator
David Ogez
Competition
Priorité Patient 2
Status
Ongoing
Budget
$200,000
See the project
Targeting genome instability as an essential vulnerability in ovarian cancer – EMC2
Principal Investigators
Anne-Marie Mes-Masson
Francis Rodier
Jean-Yves Masson
Competition
EMC2
Status
Ongoing
Budget
$1,500,000
Partners
Cancer Research Society
Genome Quebec
IRICoR
See the project
Development of precision therapeutic vaccines against acute myeloid and lymphoid leukemia – EMC2
Principal Investigator
Claude Perreault
Competition
EMC2
Status
Ongoing
Budget
$1,500,000
Partners
Cancer Research Society
CQDM
See the project
Therapeutic vulnerabilities in acute leukemia – EMC2
Principal Investigator
Trang Hoang
Competition
EMC2
Status
Ongoing
Budget
$1,500,000
Partners
Cancer Research Society
See the project
Targetable vulnerabilities to overcome drug resistance in poor outcome breast cancers – EMC2
Principal Investigators
Morag Park
Michael Pollack
Sylvie Mader
Competition
EMC2
Status
Ongoing
Budget
$1,500,000
Partners
Cancer Research Society
Genome Québec
See the project
Optimizing care for castration-resistant prostate cancer patients using triple-tracer molecular imaging and targeted radioligand therapy – EMC2
Principal Investigators
Brigitte Guérin
Frédéric Pouliot
Jean-Mathieu Beauregard
Competition
EMC2
Status
Ongoing
Budget
$1,500,000
Partner
Cancer Research Society
See the project
Montreal Cancer Consortium (MCC)
This pilot project will build on ecosystem forces while fostering new collaborations between research centres and research-oriented hospitals in Montreal to initially focus on immunotherapy treatments for melanoma and acute leukemia. This is the second pilot project launched by the Terry Fox Research Institute as part of its strategy to form a pan-Canadian network of linked cancer centres from coast to coast.
Oncopole contribution
$750,000
See the project
Establishing a chemogenomic screening pipeline for high risk acute pediatric leukemias – EMC2
Principal Investigators
Brian Wilhelm
Frédéric Barabé
Sonia Cellot
Competition
EMC2
Status
Ongoing
Budget
$1,500,000
Partners
Cancer Research Society
Genome Québec
IRICoR
See the project
Collaborative governance in the Quebec Cancer Network – EMC2
Principal Investigators
Dominique Tremblay
Nassera Touati
Competition
EMC2
Status
Ongoing
Budget
$910,851
Partners
Cancer Research Society
See the project
2018 Cohort for Scholarship Competition – Entrepreneurship in Oncology (CEO)
Oncopole and IRICoR have joined forces to launch the Scholarship Competition – Entrepreneurship in Oncology (CEO), offering the next generation of scientists an opportunity to participate in the first edition of the Life Sciences Entrepreneurship Development Program.
See the project
Group 45 Created with Sketch.
Website by Principal